# The Effect of Rifapentine on Raltegravir

> **NCT00809718** · PHASE1 · COMPLETED · sponsor: **The University of Texas Health Science Center at San Antonio** · enrollment: 27 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Raltegravir and rifapentine

## Key facts

- **NCT ID:** NCT00809718
- **Lead sponsor:** The University of Texas Health Science Center at San Antonio
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2011-05
- **Final completion:** 2011-08
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2015-10-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00809718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00809718, "The Effect of Rifapentine on Raltegravir". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00809718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*